glp-1 studies GLP1 agonists: current and future landscape of clinical trials for patients with metabolic dysfunction GLP-1 Receptor Agonists as Treatments

Cardiovascular disease and metabolic dysfunction-associated steatotic liver disease: pathophysiology and diagnostic aspects

Pediatr.Neonatol

Selenium status in elderly: relation to cognitive decline

When you cant face a forever thing Levy says she often counsels patients who are reluctant to view weight-management medication as long-term treatment and talks them through the pros and cons

Are they health literate with the possible side effects, risks or outcomes of this additional dose? I would encourage our readers to think: Lets be smart, strategic, and savvy when using some of these tools, but prioritize safety, Richard added.